Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Bipolar Disorder Treatment Market Share, Size, Growth, Forecast: By Type: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder; By Mechanism of Action: Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Others; By Diagnosis Method; By Treatment Method; By Treatment Channel; Regional Analysis; Supplier Landscape; 2023-2031

Global Bipolar Disorder Treatment Market Outlook

The global bipolar disorder treatment market attained a value of USD 5.3 billion in 2022. The market is expected to grow at a CAGR of 2.5% during the forecast period of 2023-2031 to attain a value of USD 6.7 billion by 2031. The growth of the market can be attributed to the rising cases of mental, sexual, and emotional abuse across the globe.

 

Bipolar Disorder Treatment Market: Introduction and Insights

Bipolar disorder refers to a mental illness which is also known as manic depression. In this condition, the patient experiences extreme mood swings and goes through highs and lows of emotions. These mood swings can jeopardize the patients’ health by affecting their sleep cycle, energy levels, daily activities. It can also severely affect their ability to judgment, their behaviour, and the capacity of making any decision clearly. While some people experience these mood swings at repeated occasions, others do not experience major symptoms. 

 

Bipolar disorder is a manageable condition if the patient manages to control and handle their mood swings, along with a little help from the physician, it always poses the threat to turn into severe depression, which can be fatal as the patient can become violent and even suicidal. 

 

The condition can become worse if not taken care of within time, and this can be done by observing the symptoms in the patient. Some of the most common symptoms of the disease are as follows:

 

  • Poor Decision-Making
  • Sudden Mood Changes
  • Loss of Interest/ Concentration
  • Drastic Change in Appetite- Significant Weight Loss/Gain
  • Insomnia/ Sleeping Too Much
  • Lack of motivation
  • Fatigue
  • Feelings of Worthlessness/ Excessive Guilt
  • Suicidal Thoughts
  • Others

 

Bipolar Disorder Treatment Market Segmentations

This report categorises the global bipolar disorder market into the following segmentations:

 

Market Breakup by Type

  • Bipolar I Disorder- The condition where the patient has the history of one manic episode, with the follow-up by a hypomanic or depressive episode. There are high chances that the episode could have worked as a break from reality.
  • Bipolar II Disorder- The patient has had at least one major depressive episode, along with a hypomanic episode, with no history of any manic episode.
  • Cyclothymic Disorder- This is when the episodes have occurred twice, whether once in a few years, or once during childhood and then in teenage years.

 

Market Breakup by Mechanism of Action

  • Tricyclic Antidepressants
  • Monoamine Oxidase Inhibitors
  • Benzodiazepines
  • Serotonin-Norepinephrine Reuptake Inhibitors
  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Others

 

Market Breakup by Diagnosis Method

  • Physical Exam
  • Psychiatric Assessment
  • Mood Charting

 

Bipolar Disorder Treatment Market Breakup by Treatment Method

  • Physical
    • Non-Pharmaceuticals
      • Acupuncture
      • Bright Light Therapy
      • Exercise Therapy
      • Sleep Deprivation
      • Vagus Nerve Stimulation
    • Pharmaceuticals
      • Mood Stabilizers
      • Antidepressants
      • Antipsychotics
      • Adjunctive and Alternative Treatments
  • Psychotherapy
    • Therapies
      • Cognitive Behavioural Therapy
      • Group Therapy
      • Interpersonal and Social Rhythm Therapy
      • Vocational Therapy

 

Market Breakup by Treatment Channel

  • Public
  • Private

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Bipolar Disorder Market Scenario

According to WHO, 40 million people across the world experienced bipolar disorder in 2019. The prevalence of mental disorders is rising at an alarming rate due to the rising stress among people. About 970 million people, that is one out of eight people, is suffering from some or the other mental disorder. The prevalence rate and incidence rate of the disorder is rising constantly across the globe. While treatment exists, the biggest problem is that the awareness about the treatment is extremely low, along with the restricted access to help and effective care. 

 

While most of the people are gradually understanding the importance of addressing mental health issues, it is still considered as a taboo in many regions, which makes it difficult for the patients to ask for help, leading to more suicides. 

 

Treatments and Therapies Used in the Global Bipolar Disorder Treatment Market

PHYSICAL

Non-Pharmaceutical Therapies

The physician would first approach the non-pharmaceutical treatment by suggesting some exercised that can help the patient to relax and attain relief from some of the major symptoms of the condition.

 

  • Exercising daily for more than half an hour can help the patient in releasing the stress hormones and also help in regulating circulation, appetite, and sleep cycle, among many other benefits. Further, the doctor would recommend acupuncture and bright light therapy.
  • Acupuncture is used to stimulate the nervous system, which in turn, helps in releasing certain chemicals in the body, especially the brain, spinal cord, and muscles. This leads to higher stimulation of body’s ability to heal naturally. Acupuncture significantly helps in attaining emotional, physical, and mental well-being, helping the patient to a large extent.
  • Bright light therapy or phototherapy, on the other hand, helps in regulating the sleep cycle. This therapy helps in gradual shifting of the sleep patterns to the normal levels. In this therapy, timing of light exposure plays a critical role as light should be delivered to the retina for spontaneous awakening. This would help the person to wake up on time so that they are able to sleep on time and thus the sleep cycle is fixed. Healthy sleep cycle automatically reduces the possibility of mood swings and irritability in a person as they are no longer sleep-deficient. It also helps them in being calm and helps their mind function more efficiently.
  • Vagus nerve stimulation refers to the treatment where a device is used for stimulating the vagus nerve (which runs through the brainstem from the neck to the chest and then down to the abdomen) using electrical impulses. It is a widely used treatment for conditions like depression and epilepsy. This treatment is also known as the ‘pacemaker of the brain’ because it brings changes in the working of the brain cells.

 

Pharmaceutical Therapies

The physician usually just prescribes medicines like mood stabilizers, antidepressants, second-generation (atypical) neuroleptics, also known as antipsychotics. Mood stabilizers include drugs with lithium or valproate content. These two can help restrict/prevent the episodes of mood swings or reduce their severity. Lithium also helps in decreasing the risk of suicide and suicidal thoughts. These drugs are also help induce sleep in insomniac patients for some time, till the time their pattern is regulated.

 

PSYCHOTHERAPY

Psychotherapy is widely regarded as the most effective treatment as it helps the patient to talk about the emotions, thoughts, and behaviours. This helps them let loose of the build up that might have been there for years. The talk therapy helps the patients talk to their physicians without being worried about being judged or mistreated. This can help them get relief from majority of the symptoms as they are able to express their emotions in a much better way.

 

The psychotherapies have evolved drastically in the past few years due to the rising awareness about its importance among people. With the rising awareness about the importance of addressing mental health issues and the increased support from the government, the demand for psychotherapy is now rising at a rapid pace. This is propelling the bipolar disorder treatment market development. The major therapies include cognitive behavioural therapy, group therapy, vocational therapy interpersonal and social rhythm therapy.

 

Competitive Landscape of the Bipolar Disorder Treatment Market

The report gives an in-depth analysis of the key players involved in the bipolar disorder treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • GlaxoSmithKline Plc.
  • Novartis International AG
  • Takeda Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Allergan Plc. (AbbVie Inc)
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Company
  • Astellas Pharma Inc.
  • Johnson And Johnson Services, Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2016-2022
Forecast Period 2023-2031
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Mechanism of Action
  • Diagnosis Method
  • Treatment Method
  • Treatment Channel
  • Region
Breakup by Type
  • Bipolar I Disorder
  • Bipolar II Disorder
  • Cyclothymic Disorder
Breakup by Mechanism of Action
  • Tricyclic Antidepressants
  • Monoamine Oxidase Inhibitors
  • Benzodiazepines
  • Serotonin-Norepinephrine Reuptake Inhibitors
  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Others
Breakup by Diagnosis Method
  • Physical Exam
  • Psychiatric Assessment
  • Mood Charting
Breakup by Treatment Method
  • Physical
    • Non-Pharmaceuticals
    • Pharmaceuticals
  • Psychotherapy
    • Therapies
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • GlaxoSmithKline Plc.
  • Novartis International AG
  • Takeda Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Allergan Plc. (AbbVie Inc)
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Company
  • Astellas Pharma Inc.
  • Johnson And Johnson Services, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objectives
        1.1.2    Key Findings of the Report
    1.2    Limitations of the Study and Scope for Future Research
2    Research Methodology
3    Executive Summary
4    Global Bipolar Disorder Overview

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway 
5    Patient Profile
    5.1    Patient Profile Overview 
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Global Bipolar Disorder Treatment Market
    6.1    Global Bipolar Disorder Treatment Market Overview
    6.2    Global Bipolar Disorder Treatment Market Analysis 
        6.2.1    Market Overview
            6.2.1.1    Global Bipolar Disorder Treatment Market Historical Value (2016-2022) 
            6.2.1.2    Global Bipolar Disorder Treatment Market Forecast Value (2023-2031)
    6.3    Global Bipolar Disorder Treatment Market by Type
        6.3.1    Market Overview
            6.3.1.1    Bipolar I Disorder
            6.3.1.2    Bipolar II Disorder
            6.3.1.3    Cyclothymic Disorder
    6.4    Global Bipolar Disorder Treatment Market by Mechanism of Action
        6.4.1    Market Overview
            6.4.1.1    Tricyclic Antidepressants 
            6.4.1.2    Monoamine Oxidase Inhibitors 
            6.4.1.3    Benzodiazepines 
            6.4.1.4    Serotonin-Norepinephrine Reuptake Inhibitors 
            6.4.1.5    Beta-Blockers 
            6.4.1.6    Selective Serotonin Reuptake Inhibitors 
            6.4.1.7    Others
    6.5    Global Bipolar Disorder Treatment Market by Diagnosis Method 
        6.5.1    Market Overview
            6.5.1.1    Physical Exam
            6.5.1.2    Psychiatric Assessment 
            6.5.1.3    Mood Charting 
    6.6    Global Bipolar Disorder Treatment Market by Treatment Method
        6.6.1    Market Overview
            6.6.1.1    Physical
                6.6.1.1.1    Non-Pharmaceuticals
                    6.6.1.1.1.1    Acupuncture
                    6.6.1.1.1.2    Bright Light Therapy
                    6.6.1.1.1.3    Exercise Therapy
                    6.6.1.1.1.4    Sleep Deprivation
                    6.6.1.1.1.5    Vagus Nerve Stimulation
                6.6.1.1.2    Pharmaceuticals
                    6.6.1.1.2.1    Mood Stabilizers
                    6.6.1.1.2.2    Antidepressants
                    6.6.1.1.2.3    Antipsychotics
                    6.6.1.1.2.4    Adjunctive and Alternative Treatments
            6.6.1.2    Psychotherapy
                6.6.1.2.1    Therapies
                    6.6.1.2.1.1    Cognitive Behavioural Therapy
                    6.6.1.2.1.2    Group Therapy
                    6.6.1.2.1.3    Interpersonal and Social Rhythm Therapy
                    6.6.1.2.1.4    Vocational Therapy
    6.7    Global Bipolar Disorder Treatment Market by Treatment Channel
        6.7.1    Public
        6.7.2    Private
    6.8    Global Bipolar Disorder Treatment Market by Region
        6.8.1    Market Overview
            6.8.1.1    North America 
                6.8.1.1.1    Historical Trend (2016-2022)
                6.8.1.1.2    Forecast Trend (2023-2031)
            6.8.1.2    Europe
                6.8.1.2.1    Historical Trend (2016-2022)
                6.8.1.2.2    Forecast Trend (2023-2031)
            6.8.1.3    Asia Pacific
                6.8.1.3.1    Historical Trend (2016-2022)
                6.8.1.3.2    Forecast Trend (2023-2031)
            6.8.1.4    Latin America
                6.8.1.4.1    Historical Trend (2016-2022)
                6.8.1.4.2    Forecast Trend (2023-2031)
            6.8.1.5    Middle East and Africa
                6.8.1.5.1    Historical Trend (2016-2022)
                6.8.1.5.2    Forecast Trend (2023-2031)
7    North America Bipolar Disorder Treatment Market
    7.1    United States of America
        7.1.1    Historical Trend (2016-2022)
        7.1.2    Forecast Trend (2023-2031)
    7.2    Canada 
        7.2.1    Historical Trend (2016-2022)
        7.2.2    Forecast Trend (2023-2031)
8    Europe Bipolar Disorder Treatment Market
    8.1    United Kingdom
        8.1.1    Historical Trend (2016-2022)
        8.1.2    Forecast Trend (2023-2031)
    8.2    Germany
        8.2.1    Historical Trend (2016-2022)
        8.2.2    Forecast Trend (2023-2031)
    8.3    France
        8.3.1    Historical Trend (2016-2022)
        8.3.2    Forecast Trend (2023-2031)
    8.4    Italy
        8.4.1    Historical Trend (2016-2022)
        8.4.2    Forecast Trend (2023-2031)
9    Asia Pacific Bipolar Disorder Treatment Market
    9.1    China
        9.1.1    Historical Trend (2016-2022)
        9.1.2    Forecast Trend (2023-2031)
    9.2    Japan
        9.2.1    Historical Trend (2016-2022)
        9.2.2    Forecast Trend (2023-2031)
    9.3    India
        9.3.1    Historical Trend (2016-2022)
        9.3.2    Forecast Trend (2023-2031)
    9.4    ASEAN
        9.4.1    Historical Trend (2016-2022)
        9.4.2    Forecast Trend (2023-2031)
    9.5    Australia
        9.5.1    Historical Trend (2016-2022)
        9.5.2    Forecast Trend (2023-2031)
10    Latin America Bipolar Disorder Treatment Market
    10.1    Brazil
        10.1.1    Historical Trend (2016-2022)
        10.1.2    Forecast Trend (2023-2031)
    10.2    Argentina
        10.2.1    Historical Trend (2016-2022)
        10.2.2    Forecast Trend (2023-2031)
    10.3    Mexico
        10.3.1    Historical Trend (2016-2022)
        10.3.2    Forecast Trend (2023-2031)
11    Middle East and Africa Bipolar Disorder Treatment Market
    11.1    Saudi Arabia
        11.1.1    Historical Trend (2016-2022)
        11.1.2    Forecast Trend (2023-2031)
    11.2    United Arab Emirates
        11.2.1    Historical Trend (2016-2022)
        11.2.2    Forecast Trend (2023-2031)
    11.3    Nigeria
        11.3.1    Historical Trend (2016-2022)
        11.3.2    Forecast Trend (2023-2031)
    11.4    South Africa
        11.4.1    Historical Trend (2016-2022)
        11.4.2    Forecast Trend (2023-2031)
12    Current Scenario Evaluation and Regulatory Framework
    12.1    Emerging Therapies and Clinical Trials Synopsis
    12.2    Patent Landscape
        12.2.1    Patent Overview
            12.2.1.1    Patent Status and Expiry
            12.2.1.2    Timelines from Drug Development to Commercial Launch
            12.2.1.3    New Drug Application
                12.2.1.3.1    Documentation and Approval Process
    12.3    Cost of Treatment
    12.4    Regulatory Framework
        12.4.1    Regulatory Overview
            12.4.1.1    US FDA
            12.4.1.2    EU EMA
            12.4.1.3    INDIA CDSCO
            12.4.1.4    JAPAN PMDA
            12.4.1.5    Others
13    Challenges and Unmet Needs
    13.1    Treatment Pathway Challenges
    13.2    Compliance and Drop-Out Analysis
    13.3    Awareness and Prevention Gaps
14    Global Bipolar Disorder Treatment Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model
    14.4    Key Demand Indicators 
    14.5    Key Price Indicators
    14.6    Industry Events, Initiatives and Trends  
    14.7    Value Chain Analysis
15    Supplier Landscape
    15.1    GlaxoSmithKline Plc.
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    Novartis International AG
        15.2.1    Company Overview
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications
    15.3    Takeda Pharmaceutical Industries Ltd.
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Pfizer Inc.
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Allergan Plc. (AbbVie Inc)
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    AstraZeneca Plc.
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    Bristol-Myers Squibb Co.
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    Eli Lilly and Company 
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    Astellas Pharma Inc. 
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
    15.10    Johnson And Johnson Services, Inc.
        15.10.1    Company Overview
        15.10.2    Product Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisitions
        15.10.5    Certifications
16    Recommendations and Discussion
17    Global Bipolar Disorder Treatment Drugs Distribution Model (Additional Insight)

    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment 
18    Payment Methods (Additional Insight)
    18.1    Government Funded
    18.2    Private Insurance
    18.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The bipolar disorder treatment market attained a value of nearly USD 5.3 billion in 2022.

The market is projected to grow at a CAGR of 2.5% during the forecast period of 2023-2031.

The market is estimated to witness a healthy growth in the forecast period of 2023-2031 to reach USD 6.7 billion by 2031.

The growth of the market is driven by factors like rising prevalence of anxiety, ADHD, and other mental health issues.

The rising awareness about the importance of addressing mental health issues is driving the growth of the market.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The types of the disease can be categorised into bipolar I disorder, bipolar II disorder, and cyclothymic disorder.

The mechanism of action includes Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Serotonin-Norepinephrine Reuptake Inhibitors, Beta-Blockers, and Selective Serotonin Reuptake Inhibitors, among others.

The diagnostic methods for the disease include physical exam, psychiatric assessment, and mood charting.

The treatment methods include physical therapy and psychotherapy. Physical therapy can be divided into non-pharmaceuticals and pharmaceutical treatment. Non-pharmaceuticals include acupuncture, bright light therapy, exercise therapy, sleep deprivation, and vagus nerve stimulation. Pharmaceuticals include mood stabilizers, antidepressants, antipsychotics, adjunctive and alternative treatments. Psychotherapy includes therapies like cognitive behavioural therapy, group therapy, interpersonal and social rhythm therapy, and vocational therapy.

The treatment channels in the market include public and private channels.

The key players in the market include GlaxoSmithKline Plc., Novartis International AG, Takeda Pharmaceutical Industries Ltd., Pfizer Inc., AstraZeneca Plc., Bristol-Myers Squibb Co., Eli Lilly and Company, Astellas Pharma Inc., Johnson and Johnson Services, Inc., and Allergan Plc. (AbbVie Inc).

Purchase Full Report

Mini Report

$2499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$6499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$7999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER